Unfortunately some errors appeared in this paper.
In Table 1, ‘Potential decrease MIb’ should have appeared as an Advantage, not Disadvantage, for Thiazolidinediones (glitazones).
In Figure 1, the footnote for ‘Intensive insulin + metformin ± glitazone’ should have been b not c.
In the Discussion, the sentence: ‘These findings have led to a stronger (black box) warning in the prescribing information for the thiazolidinediones [15]’ should have read:
‘These findings have led to a stronger ‘black box’ warning in the prescribing information for rosiglitazone regarding the risk for myocardial infarction and for both thiazolidinediones regarding the risk for CHF [15]’.
Reference 15: The website was last accessed on 17 November 2007, not 25 October 2007.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00125-007-0873-z.
Rights and permissions
About this article
Cite this article
Nathan, D.M., Buse, J.B., Davidson, M.B. et al. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 51, 522 (2008). https://doi.org/10.1007/s00125-007-0917-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-007-0917-4